FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/105078 [Registered on: 27/02/2026] Trial Registered Prospectively
Last Modified On: 26/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Trinpanchmooladi Ghrita Uttarbasti and Mutradahaantak Churna effect in the Pittaj Mutrakrichhra (Urinary Tract Infection) 
Scientific Title of Study   A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Trinpanchmooladi Ghrita Uttarbasti and Mutradahaantak Churna in the Management of Pittaj Mutrakrichhra w.s.r. to Urinary Tract Infection 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIl  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof Anil Bhardwaj 
Designation  Professor and Head 
Affiliation  Rajiv Gandhi Government.Post Graduate College and Hospital Paprola District Kangra Himachal Pradesh 
Address  Room no.203 PG Department of Panchkarma RGGPGACH Paprola Tehsil Baijnath District Kangra HP

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418466766  
Fax    
Email  anil5karma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Anil Bhardwaj 
Designation  Professor and Head 
Affiliation  Rajiv Gandhi Government.Post Graduate College and Hospital Paprola District Kangra Himachal Pradesh 
Address  Room no.203 PG Department of Panchkarma RGGPGACH Paprola Tehsil Baijnath District Kangra HP

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418466766  
Fax    
Email  anil5karma@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sneh Rathore 
Designation  PG Scholar 
Affiliation  Rajiv Gandhi Government.Post Graduate College and Hospital Paprola District Kangra Himachal Pradesh 
Address  Room no.701 PG Department of Panchkarma RGGPGACH Paprola Tehsil Baijnath District Kangra HP

Kangra
HIMACHAL PRADESH
176115
India 
Phone  7018387925  
Fax    
Email  snehrathore85@gmail.com  
 
Source of Monetary or Material Support  
Baijnath Pharmacy Paprola District Kangra HP Charak Pharmacy Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola District Kangra HP Research institute in ISM Jogindernagar District Mandi Himachal Pradesh  
 
Primary Sponsor  
Name  RGGPG Ayurvedic college  
Address  RGGPG Ayurvedic College and Hospital kangra 176115 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prof Anil Bhardwaj  Rajiv Gandhi Government Post graduate Ayurvedic College and Hospital Paprola   Room No. 203 Department of Panchkarma Rajiv Gandhi Government Post graduate Ayurvedic College and Hospital Paprola District Kangra HP
Kangra
HIMACHAL PRADESH 
9418466766

anil5karma@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics commitee (Human) Rajiv Gandhi Govt.Post Graduate college and Hospital Paprola Distt.kangra H.P.176115 India   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-NitrofurantoinNitrofurantoin 100mg BD after meal orally for 7 days
2Comparator ArmDrugClassical(1) Medicine Name: mutradahaantak churana, Reference: Rasatantrasaar Va sidhprayoga sangraha (part2)page -378-379, Route: Oral, Dosage Form: Churna/ Powder, Dose: 250(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: -chandanaadi Arka ), Additional Information: -chandanaadi arka 20ml TID refernce sidh prayog sangrah page no.3
3Intervention ArmProcedure-uttara-basti, उत्तर-बस्तिः (Procedure Reference: sushruta uttar 29/20,21, Procedure details: Purva karma-collection of material,vital monitoring Pradhan karma-micuration before procedure, postioning of patient,insertion of Foleys catheter ,pushing of medicine into bladder,removal of Foleys catheter,rest for 15 min. Paschat karma- vital monitoring,light food intake )
(1) Medicine Name: Trinpanchmooladi ghrita, Reference: Vangsen samhita ashmari aadhyaya (52-55), Route: Urethral, Dosage Form: Ghrita, Dose: 40(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  i. Patients present with sign and symptoms of Pittaj Mutrakrichhra and Urinary tract infection as mentioned in diagnostic criteria.
ii. Patient willing to participate.
iii. Patients in the age group of 25-70 years.
 
 
ExclusionCriteria 
Details  i. Patients not willing for trial.
ii. Known case of Ureteric stone, Pyelonephritis, Polycystic Kidney Disease, Neurogenic Bladder urethral stricture
iii. Patient with uncontrolled Hypertension, Diabetes Mellitus, Malignancy, anorectal disease and other chronic illness.
iv. Pregnant & lactating women.
v. Patient suffering from chronic illness requiring immediate hospitalization.
vi. Any condition which the investigator thinks may compromise with the safety of the patient
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To fulfil subjective and objective criterian Efficacy and effect of trinpanchmooladi ghrita and mutradahaantak churana on growth of micro-organism causing Urinary Tract Infection.
To observe untoward effect of Uttarbasti in the patients of UTI if any.
To evaluate the efficacy and treatment protocol with –Nitrofurantoin
 
7 days 
 
Secondary Outcome  
Outcome  TimePoints 
To observe untoward effect of Uttarbasti in the patients of UTI if any
To evaluate the efficacy & treatment protocol with Nitrofurantoin
 
7 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   I would like to publish my research trail after completion as soon as possible. A total of 30 subjects  will be studied in 3 groups.10 study participant will  be managed with Trinpanchmooladi ghrita uttar basti and 10 will be managed with Mutradahaantak churana with Chandanaadi arka as anupana and in rest 10 participant nitrofurantoin will be given. 
Close